Comparison of three different tests for assessment of hepatitis C virus in dialysis patients

C. Casteinovo, G. Lunghi, A. De Vecchi, A. Grancini, G. Como, G. Graziani, A. Scalamogna, C. Ponticelli

Research output: Contribution to journalArticle

7 Citations (Scopus)

Abstract

Objective: To evaluate the relationship between hepatitis C virus antibodies (HCV-Ab) and viremia and to compare the prevalence of HCV-Ab and HCV viremia in hemodialysis (HD) and continuous ambulatory peritoneal dialysis (CAPD) patients. Design: Cross-sectional study. Setting: Dialysis unit of a nephrology division in a public university hospital. Patients: All dialysis patients who came for routine clinic visits during the study period. None denied informed consent. Forty-eight patients on HD and 79 on CAPD were examined. Intervention: Blood samples were tested by second-generation enzyme-linked immunosorbent assay (ELISA II) and recombinant immunoblot assay (RIBA II) to look for HCV-Ab and by the polymerase chain reaction (PCR) to look for HCV viremia. Results: ELISA II was positive in 52% of HD patients and in 14% of CAPD patients. RIBA II was positive in 48% of HD patients and in 11% of CAPD patients. HCV viremia was positive by PCR in 41.6% of HD patients and in 12% of CAPD patients. Two of these PCR-positive patients did not show HCV-Ab by ELISA II and RIBA II. The sensitivity and specificity of ELISA II were 93% and 92%, the sensitivity and specificity of RIBA II were 86% and 94%. Conclusions: Our data confirm a higher prevalence of HCV viremia in HD than in CAPD patients. The absence of Ab against virus C in 2 patients positive with PCR might be due to recent HCV infection or to weak virus replication or to a poor immune response.

Original languageEnglish
Pages (from-to)241-245
Number of pages5
JournalPeritoneal Dialysis International
Volume15
Issue number6
Publication statusPublished - 1995

Fingerprint

Hepacivirus
Dialysis
Continuous Ambulatory Peritoneal Dialysis
Viremia
Renal Dialysis
Hepatitis C Antibodies
Enzyme-Linked Immunosorbent Assay
Polymerase Chain Reaction
Sensitivity and Specificity
Nephrology
Public Hospitals
Ambulatory Care
Virus Replication
Informed Consent
Cross-Sectional Studies
Viruses

Keywords

  • Hepatitis C virus
  • Liver infections
  • Viral hepatitis

ASJC Scopus subject areas

  • Nephrology

Cite this

Comparison of three different tests for assessment of hepatitis C virus in dialysis patients. / Casteinovo, C.; Lunghi, G.; De Vecchi, A.; Grancini, A.; Como, G.; Graziani, G.; Scalamogna, A.; Ponticelli, C.

In: Peritoneal Dialysis International, Vol. 15, No. 6, 1995, p. 241-245.

Research output: Contribution to journalArticle

Casteinovo, C, Lunghi, G, De Vecchi, A, Grancini, A, Como, G, Graziani, G, Scalamogna, A & Ponticelli, C 1995, 'Comparison of three different tests for assessment of hepatitis C virus in dialysis patients', Peritoneal Dialysis International, vol. 15, no. 6, pp. 241-245.
Casteinovo, C. ; Lunghi, G. ; De Vecchi, A. ; Grancini, A. ; Como, G. ; Graziani, G. ; Scalamogna, A. ; Ponticelli, C. / Comparison of three different tests for assessment of hepatitis C virus in dialysis patients. In: Peritoneal Dialysis International. 1995 ; Vol. 15, No. 6. pp. 241-245.
@article{f78e6d33d29c43deb83ae34dc8692518,
title = "Comparison of three different tests for assessment of hepatitis C virus in dialysis patients",
abstract = "Objective: To evaluate the relationship between hepatitis C virus antibodies (HCV-Ab) and viremia and to compare the prevalence of HCV-Ab and HCV viremia in hemodialysis (HD) and continuous ambulatory peritoneal dialysis (CAPD) patients. Design: Cross-sectional study. Setting: Dialysis unit of a nephrology division in a public university hospital. Patients: All dialysis patients who came for routine clinic visits during the study period. None denied informed consent. Forty-eight patients on HD and 79 on CAPD were examined. Intervention: Blood samples were tested by second-generation enzyme-linked immunosorbent assay (ELISA II) and recombinant immunoblot assay (RIBA II) to look for HCV-Ab and by the polymerase chain reaction (PCR) to look for HCV viremia. Results: ELISA II was positive in 52{\%} of HD patients and in 14{\%} of CAPD patients. RIBA II was positive in 48{\%} of HD patients and in 11{\%} of CAPD patients. HCV viremia was positive by PCR in 41.6{\%} of HD patients and in 12{\%} of CAPD patients. Two of these PCR-positive patients did not show HCV-Ab by ELISA II and RIBA II. The sensitivity and specificity of ELISA II were 93{\%} and 92{\%}, the sensitivity and specificity of RIBA II were 86{\%} and 94{\%}. Conclusions: Our data confirm a higher prevalence of HCV viremia in HD than in CAPD patients. The absence of Ab against virus C in 2 patients positive with PCR might be due to recent HCV infection or to weak virus replication or to a poor immune response.",
keywords = "Hepatitis C virus, Liver infections, Viral hepatitis",
author = "C. Casteinovo and G. Lunghi and {De Vecchi}, A. and A. Grancini and G. Como and G. Graziani and A. Scalamogna and C. Ponticelli",
year = "1995",
language = "English",
volume = "15",
pages = "241--245",
journal = "Peritoneal Dialysis International",
issn = "0896-8608",
publisher = "Multimed Inc.",
number = "6",

}

TY - JOUR

T1 - Comparison of three different tests for assessment of hepatitis C virus in dialysis patients

AU - Casteinovo, C.

AU - Lunghi, G.

AU - De Vecchi, A.

AU - Grancini, A.

AU - Como, G.

AU - Graziani, G.

AU - Scalamogna, A.

AU - Ponticelli, C.

PY - 1995

Y1 - 1995

N2 - Objective: To evaluate the relationship between hepatitis C virus antibodies (HCV-Ab) and viremia and to compare the prevalence of HCV-Ab and HCV viremia in hemodialysis (HD) and continuous ambulatory peritoneal dialysis (CAPD) patients. Design: Cross-sectional study. Setting: Dialysis unit of a nephrology division in a public university hospital. Patients: All dialysis patients who came for routine clinic visits during the study period. None denied informed consent. Forty-eight patients on HD and 79 on CAPD were examined. Intervention: Blood samples were tested by second-generation enzyme-linked immunosorbent assay (ELISA II) and recombinant immunoblot assay (RIBA II) to look for HCV-Ab and by the polymerase chain reaction (PCR) to look for HCV viremia. Results: ELISA II was positive in 52% of HD patients and in 14% of CAPD patients. RIBA II was positive in 48% of HD patients and in 11% of CAPD patients. HCV viremia was positive by PCR in 41.6% of HD patients and in 12% of CAPD patients. Two of these PCR-positive patients did not show HCV-Ab by ELISA II and RIBA II. The sensitivity and specificity of ELISA II were 93% and 92%, the sensitivity and specificity of RIBA II were 86% and 94%. Conclusions: Our data confirm a higher prevalence of HCV viremia in HD than in CAPD patients. The absence of Ab against virus C in 2 patients positive with PCR might be due to recent HCV infection or to weak virus replication or to a poor immune response.

AB - Objective: To evaluate the relationship between hepatitis C virus antibodies (HCV-Ab) and viremia and to compare the prevalence of HCV-Ab and HCV viremia in hemodialysis (HD) and continuous ambulatory peritoneal dialysis (CAPD) patients. Design: Cross-sectional study. Setting: Dialysis unit of a nephrology division in a public university hospital. Patients: All dialysis patients who came for routine clinic visits during the study period. None denied informed consent. Forty-eight patients on HD and 79 on CAPD were examined. Intervention: Blood samples were tested by second-generation enzyme-linked immunosorbent assay (ELISA II) and recombinant immunoblot assay (RIBA II) to look for HCV-Ab and by the polymerase chain reaction (PCR) to look for HCV viremia. Results: ELISA II was positive in 52% of HD patients and in 14% of CAPD patients. RIBA II was positive in 48% of HD patients and in 11% of CAPD patients. HCV viremia was positive by PCR in 41.6% of HD patients and in 12% of CAPD patients. Two of these PCR-positive patients did not show HCV-Ab by ELISA II and RIBA II. The sensitivity and specificity of ELISA II were 93% and 92%, the sensitivity and specificity of RIBA II were 86% and 94%. Conclusions: Our data confirm a higher prevalence of HCV viremia in HD than in CAPD patients. The absence of Ab against virus C in 2 patients positive with PCR might be due to recent HCV infection or to weak virus replication or to a poor immune response.

KW - Hepatitis C virus

KW - Liver infections

KW - Viral hepatitis

UR - http://www.scopus.com/inward/record.url?scp=0029023809&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0029023809&partnerID=8YFLogxK

M3 - Article

VL - 15

SP - 241

EP - 245

JO - Peritoneal Dialysis International

JF - Peritoneal Dialysis International

SN - 0896-8608

IS - 6

ER -